SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $921K invested in Sonnet BioTherapeutics in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership: →

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$881K
2
+$16K
3
+$16K
4
RFA
Reilly Financial Advisors
California
+$8K

Top Sellers

1
-$15K
2
-$9K
3
-$7K
4
ECM
ETrade Capital Management
Virginia
-$7K
5
Northern Trust
Northern Trust
Illinois
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$881K
2
$16K
3
$16K
4
$8K
5
–
6
–
7
–
8
–
9
–
10
–